M L Morganroth

Author PubWeight™ 21.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immediate drainage is not required for all patients with complicated parapneumonic effusions. Chest 1990 1.56
2 High-frequency ventilation. Chest 1989 1.44
3 Pancreatitis-induced acute lung injury. An ARDS model. Ann Surg 1988 1.21
4 Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol 1985 1.06
5 Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mo1 monoclonal antibody. Blood 1987 1.06
6 Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat. Am J Pathol 1987 1.06
7 Surface Mo1 (CD11b/CD18) glycoprotein is up-modulated by neutrophils recruited to sites of inflammation in vivo. Inflammation 1989 0.98
8 Neutrophils are not necessary for ischemia-reperfusion lung injury. Ann Thorac Surg 1992 0.98
9 Modulation of surface CD11/CD18 glycoproteins (Mo1, LFA-1, p150,95) by human mononuclear phagocytes. Clin Immunol Immunopathol 1988 0.97
10 Prostaglandin and histaminergic mediation of prolonged vasodilation after exercise. Am J Physiol 1977 0.96
11 Criteria for weaning from prolonged mechanical ventilation. Arch Intern Med 1984 0.95
12 Neutrophils are not necessary for induction of ischemia-reperfusion lung injury. J Appl Physiol (1985) 1990 0.93
13 Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am J Respir Cell Mol Biol 1990 0.88
14 Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen. Chest 1997 0.88
15 Complement and neutrophil-mediated injury of perfused rat lungs. Lab Invest 1986 0.86
16 Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. J Appl Physiol Respir Environ Exerc Physiol 1984 0.86
17 Diethylcarbamazine inhibits acute and chronic hypoxic pulmonary hypertension in awake rats. Am Rev Respir Dis 1985 0.84
18 Leukotriene C4 production during hypoxic pulmonary vasoconstriction in isolated rat lungs. Prostaglandins 1984 0.82
19 Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury. Am Rev Respir Dis 1991 0.81
20 Xanthine oxidase inhibition attenuates ischemic-reperfusion lung injury. J Surg Res 1988 0.80
21 Prolonged vasodilation following fatiguing exercise of dog skeletal muscle. Am J Physiol 1975 0.79
22 Inhibition of rat lung glutathione synthesis attenuates hypoxic pulmonary vasoconstriction and the associated leukotriene C4 production. Am Rev Respir Dis 1989 0.77
23 Basophilic leukemia and hyperhistaminemia: a case report. Conn Med 1982 0.75
24 Weaning from the ventilator: weaning the unweabable. Am J Nurs 1987 0.75
25 Decreased pulmonary vascular responsiveness in rats raised on an essential fatty acid deficient diet. Prostaglandins 1987 0.75
26 Hypothermia or continuous ventilation decreases ischemia-reperfusion injury in an ex vivo rat lung model. Surgery 1989 0.75
27 Weaning from the ventilator: in specific clinical situations. Am J Nurs 1987 0.75
28 Cytoplasts and Mo1-deficient neutrophils pretreated with plasma and LPS induce lung injury. Am J Physiol 1989 0.75
29 Discontinuation of mechanical ventilation. Clin Chest Med 1988 0.75
30 [Inhibition of hypoxic pulmonary vasoconstriction by leukotriene blockade]. Wien Klin Wochenschr 1986 0.75
31 [Ventilator weaning]. Servir 1989 0.75
32 Neutrophil function disorders. Dis Mon 1987 0.75
33 Weaning from the ventilator: protocols that work. Am J Nurs 1987 0.75